Ginkgo Bioworks Files 8-K: Officer/Director Changes & More
Ticker: DNABW · Form: 8-K · Filed: May 21, 2025 · CIK: 1830214
| Field | Detail |
|---|---|
| Company | Ginkgo Bioworks Holdings, Inc. (DNABW) |
| Form Type | 8-K |
| Filed Date | May 21, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: leadership-change, officer-appointment, director-election, filing
TL;DR
Ginkgo Bioworks 8-K: Leadership changes, officer appointments, and compensation details filed.
AI Summary
Ginkgo Bioworks Holdings, Inc. filed an 8-K on May 21, 2025, reporting events as of May 19, 2025. The filing indicates changes related to the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements for certain officers. It also includes a Regulation FD Disclosure and Financial Statements and Exhibits.
Why It Matters
This filing signals potential shifts in the company's leadership and governance structure, which could impact strategic direction and investor confidence.
Risk Assessment
Risk Level: medium — Changes in directors or officers can indicate internal shifts that may affect company strategy or performance.
Key Players & Entities
- Ginkgo Bioworks Holdings, Inc. (company) — Registrant
- Soaring Eagle Acquisition Corp. (company) — Former Company Name
- Spinning Eagle Acquisition Corp. (company) — Former Company Name
FAQ
What specific officer or director positions were affected by the events reported on May 19, 2025?
The filing indicates "Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers" but does not specify the exact individuals or roles in the provided text.
Are the compensatory arrangements mentioned related to new hires, existing officers, or departing individuals?
The filing mentions "Compensatory Arrangements of Certain Officers" but does not provide details on whether these are for new, existing, or departing officers in the provided text.
What is the nature of the Regulation FD Disclosure included in this filing?
The filing lists "Regulation FD Disclosure" as an item but does not elaborate on its content in the provided text.
What financial statements or exhibits are being filed alongside this 8-K?
The filing states "Financial Statements and Exhibits" are included, but the specific documents are not detailed in the provided text.
When was Ginkgo Bioworks Holdings, Inc. previously known as Soaring Eagle Acquisition Corp. or Spinning Eagle Acquisition Corp.?
Ginkgo Bioworks Holdings, Inc. was formerly known as Soaring Eagle Acquisition Corp. after a name change on February 10, 2021, and prior to that, as Spinning Eagle Acquisition Corp. after a name change on October 27, 2020.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 21, 2025 regarding Ginkgo Bioworks Holdings, Inc. (DNABW).